Consecutive hypoglycemia attacks induced by co-trimoxazole followed by pentamidine in a patient with acquired immunodeficiency syndrome

Int J STD AIDS. 2019 Jan;30(1):86-89. doi: 10.1177/0956462418795580. Epub 2018 Aug 31.

Abstract

Both co-trimoxazole and pentamidine are used for the treatment of pneumocystis pneumonia (PCP) and are known to cause hypoglycemia as an adverse drug reaction. Here, we describe a rare case of a late-diagnosed female patient with acquired immunodeficiency syndrome (AIDS) who developed the first hypoglycemic attack as an adverse effect of co-trimoxazole, followed by a second hypoglycemic attack as an adverse effect of pentamidine. Physicians caring for patients with AIDS and PCP should be aware of possible hypoglycemia in patients with many risk factors.

Keywords: Hypoglycemia; Pneumocystis pneumonia; co-trimoxazole; pentamidine.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Aged
  • Anti-Infective Agents / therapeutic use*
  • Atovaquone / therapeutic use*
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Humans
  • Hypoglycemia / chemically induced*
  • Pentamidine / adverse effects*
  • Pentamidine / therapeutic use
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / drug therapy*
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Infective Agents
  • Pentamidine
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Atovaquone